Skip to content

1. Current Status, Position

Paul Cornes (BM BCH) is oncologist in Bristol. He is working for the Comparative Outcomes Group.

2. Education

Dr. Cornes is a Bachelor of Medicine, Bachelor of Surgery. He is part of the steering group for the European School of Oncology Working Party on the Access to Innovation in Cancer Treatment as well as faculty for the annual ECCO European CanCer Organisation meeting – speaking on Innovation and cost-effective care. He took the same role for the Rotating Presidency Meeting of the EU Health Ministry in Riga. He encourages physicians that health economics is to be embraced as part of routine medical practice.

3. Research Area

Paul Cornes was part of the team that developed and presented evidence for the first successful US biosimilar to the Oncology Advisory drugs Committee of the FDA. He is part of the British Medical Journal “Round Table” group on Biosimilars as well as a faculty for the forthcoming DIA Regulators Meeting on Biosimilars. In 2015, he was the physician panel member for the European Commission Biosimilars meeting.

4. Conflict of interest: He is a speaker for Accord Healthcare, Bernstein, European Generics Association, Hospira, Merk Serono, Napp, Pfizer and Sandoz.

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.